112 related articles for article (PubMed ID: 29922995)
1. In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin.
Kuzmin DV; Emel'yanova AA; Kalashnikova MB; Panteleev PV; Ovchinnikova TV
Bull Exp Biol Med; 2018 Jun; 165(2):220-224. PubMed ID: 29922995
[TBL] [Abstract][Full Text] [Related]
2. Tachyplesin induces apoptosis in non-small cell lung cancer cells and enhances the chemosensitivity of A549/DDP cells to cisplatin by activating Fas and necroptosis pathway.
Wu J; Chen X; Zhang J; Chen J; Wang Y; Wei T; Ma J; Li Y; Mo T; He Z; Zhang H
Chem Biol Drug Des; 2021 Apr; 97(4):809-820. PubMed ID: 33245189
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.
Edwards IA; Elliott AG; Kavanagh AM; Blaskovich MAT; Cooper MA
ACS Infect Dis; 2017 Dec; 3(12):917-926. PubMed ID: 28960954
[TBL] [Abstract][Full Text] [Related]
4. Efflux of potassium ion is an important reason of HL-60 cells apoptosis induced by tachyplesin.
Zhang HT; Wu J; Zhang HF; Zhu QF
Acta Pharmacol Sin; 2006 Oct; 27(10):1367-74. PubMed ID: 17007745
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
Hong J; Guan W; Jin G; Zhao H; Jiang X; Dai J
Microbiol Res; 2015 Jan; 170():69-77. PubMed ID: 25267486
[TBL] [Abstract][Full Text] [Related]
6. Effects of tachyplesin I on human U251 glioma stem cells.
Ding H; Jin G; Zhang L; Dai J; Dang J; Han Y
Mol Med Rep; 2015 Apr; 11(4):2953-8. PubMed ID: 25434611
[TBL] [Abstract][Full Text] [Related]
7. Modified horseshoe crab peptides target and kill bacteria inside host cells.
Amiss AS; von Pein JB; Webb JR; Condon ND; Harvey PJ; Phan MD; Schembri MA; Currie BJ; Sweet MJ; Craik DJ; Kapetanovic R; Henriques ST; Lawrence N
Cell Mol Life Sci; 2021 Dec; 79(1):38. PubMed ID: 34971427
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.
Vernen F; Harvey PJ; Dias SA; Veiga AS; Huang YH; Craik DJ; Lawrence N; Troeira Henriques S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31455019
[TBL] [Abstract][Full Text] [Related]
9. D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line.
Evans HG; Guthrie JW; Jujjavarapu M; Hendrickson N; Eitel A; Park Y; Garvey J; Newman R; Esckilsen D; Heyl DL
Protein Pept Lett; 2017; 24(7):590-598. PubMed ID: 28641565
[TBL] [Abstract][Full Text] [Related]
10. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
Shi SL; Wang YY; Liang Y; Li QF
World J Gastroenterol; 2006 Mar; 12(11):1694-8. PubMed ID: 16586536
[TBL] [Abstract][Full Text] [Related]
11. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE
Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563
[TBL] [Abstract][Full Text] [Related]
12. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.
Shi J; So LY; Chen F; Liang J; Chow HY; Wong KY; Wan S; Jiang T; Yu R
J Pept Sci; 2018 Jun; 24(6):e3087. PubMed ID: 29870123
[TBL] [Abstract][Full Text] [Related]
13. Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms.
Hong J; Hu J; Ke F
Antimicrob Agents Chemother; 2016 Oct; 60(10):6067-75. PubMed ID: 27480861
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Mocchegiani F; Di Matteo F; Riva A; Lukasiak J; Scalise G; Saba V; Giacometti A
Antimicrob Agents Chemother; 2007 Jun; 51(6):2005-10. PubMed ID: 17403995
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides.
Kuzmin DV; Emelianova AA; Kalashnikova MB; Panteleev PV; Balandin SV; Serebrovskaya EO; Belogurova-Ovchinnikova OY; Ovchinnikova TV
Chem Biol Drug Des; 2018 Jan; 91(1):294-303. PubMed ID: 28815904
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro.
Morimoto M; Mori H; Otake T; Ueba N; Kunita N; Niwa M; Murakami T; Iwanaga S
Chemotherapy; 1991; 37(3):206-11. PubMed ID: 1889308
[TBL] [Abstract][Full Text] [Related]
17. Tachyplesin activates the classic complement pathway to kill tumor cells.
Chen J; Xu XM; Underhill CB; Yang S; Wang L; Chen Y; Hong S; Creswell K; Zhang L
Cancer Res; 2005 Jun; 65(11):4614-22. PubMed ID: 15930279
[TBL] [Abstract][Full Text] [Related]
18. Effect of N- and C-Terminal Modifications on Cytotoxic Properties of Antimicrobial Peptide Tachyplesin I.
Kuzmin DV; Emelianova AA; Kalashnikova MB; Panteleev PV; Ovchinnikova TV
Bull Exp Biol Med; 2017 Apr; 162(6):754-757. PubMed ID: 28429216
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
Cirioni O; Giacometti A; Kamysz W; Silvestri C; Riva A; Della Vittoria A; Abbruzzetti A; Lukasiak J; Scalise G
Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
